- Investigator
- Whitney W Woodmansee
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Pituitary Neoplasms , 14 publications
- Human Growth Hormone , 11 publications
- Adenoma , 9 publications
- Pituitary Gland , 8 publications
Research activity
Focus
Dr. Woodmansee has been involved in both basic science and clinical research and has numerous publications in the pituitary/thyroid field. Spending much of her career specializing in pituitary and thyroid disorders, she has also served as director of the Clinical Neuroendocrine Program at the Brigham and Women’s Hospital/ Harvard Medical School in Boston, MA and the medical director of the Neuroendocrine/Pituitary Program at the Mayo Clinic in Jacksonville, FL. Dr. Woodmansee has been a principal investigator in a number of clinical trials related to pituitary disorders and her current primary research interest is in the area of hypopituitarism. She specializes in treating patients with pituitary and thyroid disorders.
Active clinical trials
My publications
Filter publications
54 publications
2016
Functional Gonadotroph Adenomas: Case Series and Report of Literature.
Neurosurgery
PubMed2016
HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS.
AACE clinical case reports
PubMed2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.
Oncotarget
PubMed • Publisher's site2016
Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis.
Neurosurgery
PubMed • Publisher's site2015
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
PubMed • Publisher's site